216 related articles for article (PubMed ID: 15806386)
1. Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity.
Haratake M; Fukunaga M; Ono M; Nakayama M
J Biol Inorg Chem; 2005 May; 10(3):250-8. PubMed ID: 15806386
[TBL] [Abstract][Full Text] [Related]
2. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
3. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
[TBL] [Abstract][Full Text] [Related]
6. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
7. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
8. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
[TBL] [Abstract][Full Text] [Related]
9. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic potential of vanadium in treating diabetes mellitus].
Sakurai H
Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
[TBL] [Abstract][Full Text] [Related]
11. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
12. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
[TBL] [Abstract][Full Text] [Related]
13. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.
Rehder D; Costa Pessoa J; Geraldes CF; Castro MC; Kabanos T; Kiss T; Meier B; Micera G; Pettersson L; Rangel M; Salifoglou A; Turel I; Wang D
J Biol Inorg Chem; 2002 Apr; 7(4-5):384-96. PubMed ID: 11941496
[TBL] [Abstract][Full Text] [Related]
14. Reducing agents mitigate protein synthesis inhibition mediated by vanadate and vanadyl compounds in reticulocyte lysates.
Krishnamoorthy T; Sreedhara A; Rao CP; Ramaiah KV
Arch Biochem Biophys; 1998 Jan; 349(1):122-8. PubMed ID: 9439590
[TBL] [Abstract][Full Text] [Related]
15. Increased potency of vanadium using organic ligands.
McNeill JH; Yuen VG; Dai S; Orvig C
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):175-80. PubMed ID: 8927036
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
17. Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture.
Etcheverry SB; Crans DC; Keramidas AD; Cortizo AM
Arch Biochem Biophys; 1997 Feb; 338(1):7-14. PubMed ID: 9015381
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, reactivity, and catalytic potential of model vanadium(IV, V) complexes with benzimidazole-derived ONN donor ligands.
Maurya MR; Kumar A; Ebel M; Rehder D
Inorg Chem; 2006 Jul; 45(15):5924-37. PubMed ID: 16841997
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
20. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]